| MeSH term | MeSH ID | Detail |
|---|---|---|
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Starvation | D013217 | 47 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Leukemia, Erythroblastic, Acute | D004915 | 41 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Plaque, Amyloid | D058225 | 19 associated lipids |
| Disease Resistance | D060467 | 12 associated lipids |
| Riboflavin Deficiency | D012257 | 10 associated lipids |
HEXANOIC ACID
HEXANOIC ACID is a lipid of Fatty Acyls (FA) class. Hexanoic acid is associated with abnormalities such as Obesity, Ileoanal Pouches, Ulcerative Colitis, Ulcerative colitis, quiescent and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Binding (Molecular Function), Anabolism, Adjudication, enzyme activity and Process. Hexanoic acid often locates in Membrane, Tissue membrane, Microsomes, Liver, Microsomes and Mitochondria. The associated genes with HEXANOIC ACID are SH2D1A gene, Fusion Protein and MAPK3 gene. The related lipids are hexanoic acid, Fatty Acids, Butyric Acid, Propionate and Palmitates.
Cross Reference
Introduction
To understand associated biological information of HEXANOIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEXANOIC ACID?
HEXANOIC ACID is suspected in Obesity, Ileoanal Pouches, Ulcerative Colitis, Ulcerative colitis, quiescent, Diabetes Mellitus, Non-Insulin-Dependent, Gastroesophageal reflux disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEXANOIC ACID
PubChem Associated disorders and diseases
What pathways are associated with HEXANOIC ACID
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEXANOIC ACID?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Drug Metab. Dispos. (2)
- J. Biol. Chem. (2)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Others (1)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEXANOIC ACID?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEXANOIC ACID?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with HEXANOIC ACID?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEXANOIC ACID?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEXANOIC ACID
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Argirov OK et al. | 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses. | 2004 | J. Biol. Chem. | pmid:14634019 |
| Azim-Zadeh O et al. | Use of biotin derivatives to probe conformational changes in proteins. | 2007 | J. Biol. Chem. | pmid:17545162 |
| Lee IY and McMenamy RH | Location of the medium chain fatty acid site on human serum albumin. Residues involved and relationship to the indole site. | 1980 | J. Biol. Chem. | pmid:7391008 |
| Jarabak R and Westley J | Competitive partial inhibitors of serum albumin-catalyzed sulfur cyanolysis. | 1990 | J. Biochem. Toxicol. | pmid:2402002 |
| Vessey DA et al. | Monovalent cation effects on the activity of the xenobiotic/medium-chain fatty acid:CoA ligases are substrate specific. | 2000 | J. Biochem. Mol. Toxicol. | pmid:10711632 |
| Daniels C et al. | Global regulation of food supply by Pseudomonas putida DOT-T1E. | 2010 | J. Bacteriol. | pmid:20139187 |
| Okere IC et al. | Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion. | 2006 | J. Appl. Physiol. | pmid:16141384 |
| Suranadi IW et al. | An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution. | 2012 | J. Appl. Physiol. | pmid:22797310 |
| Mendonça TT et al. | Exploring the potential of Burkholderia sacchari to produce polyhydroxyalkanoates. | 2014 | J. Appl. Microbiol. | pmid:24279348 |
| Iwatsuki M et al. | Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidation. | 2008 | J. Antibiot. | pmid:18503202 |